Assunto: METÁSTASE NEOPLÁSICA
ABNT
MORIOKA, Cintia Yoko et al. Antisense therapy specific to mutated K-ras gene in hamster pancreatic cancer model.: can it inhibit the growth of 5-FU and MMC-resistant metastatic and remetastatic cell lines?. In vivo, v. 18, p. 113-118, 2004Tradução . . Acesso em: 19 out. 2024.APA
Morioka, C. Y., Saito, S., Machado, M. C. C., Ohzawa, K., Kubrusly, M. S., Cunha, J. E. M., & Watanabe, A. (2004). Antisense therapy specific to mutated K-ras gene in hamster pancreatic cancer model.: can it inhibit the growth of 5-FU and MMC-resistant metastatic and remetastatic cell lines? In vivo, 18, 113-118.NLM
Morioka CY, Saito S, Machado MCC, Ohzawa K, Kubrusly MS, Cunha JEM, Watanabe A. Antisense therapy specific to mutated K-ras gene in hamster pancreatic cancer model.: can it inhibit the growth of 5-FU and MMC-resistant metastatic and remetastatic cell lines? In vivo. 2004 ; 18 113-118.[citado 2024 out. 19 ]Vancouver
Morioka CY, Saito S, Machado MCC, Ohzawa K, Kubrusly MS, Cunha JEM, Watanabe A. Antisense therapy specific to mutated K-ras gene in hamster pancreatic cancer model.: can it inhibit the growth of 5-FU and MMC-resistant metastatic and remetastatic cell lines? In vivo. 2004 ; 18 113-118.[citado 2024 out. 19 ]